Top Story
FDA opens kimono on agency performance
The FDA is furthering its journey toward transparency with the launch of FDA-TRACK, a multi-level performance management system. "TRACK" stands for transparency, results, accountability, credibility and knowledge-sharing. Report
Latest News
Also Noted
> India-based Sun has again been slapped by the FDA for trouble in its U.S. business. Article
> Expect some flu vaccine delays now that three manufacturers are making label changes, warning U.S. healthcare providers that the syringe tip caps may contain natural rubber latex. Announcement
> A nuclear magnetic resonance technique underlies what Swedish researchers hope will become a small briefcase, into which pharmacists and customs officers can place a packet of tablets and a minute later find out whether the drug is authentic. Release
> Ombudsman programs and hotlines into neutral corporate territory, where individuals can confidentially report concerns, are ways to preserve the necessary independence of the QA group. Blog
Read more >>Latest Comments
Special Report
Top Counterfeit Drugs Report
Drug counterfeiting has become a $200-billion business annually, according to the World Customs Organization. By some calculations, the counterfeiting trade has become more lucrative than the narcotics business. It's a global problem. And experts say that solving it--or at least stemming the tide--requires the participation of both government and industry. Report
Feature
Top 10 Pharma Cargo Thefts by Value, 2009/2010
Big pharma means big money, especially for thieves. In a much publicized and spectacular heist, burglars made off with $75 million worth of drugs from an Eli Lily warehouse in Connecticut last March. That's one high-value hit. But it's just one incident in a growing crime wave targeting pharmaceuticals. Report
From The Network
Press Releases
- Cardiome Achieves $30 Million Milestone
- Generex Oncology Announces Consultancy of Dr. George E. Peoples, MD
- Revaccination Could Benefit HIV-Infected Children, Review Suggests
- Researchers Exploring 'Fusion Strategy' Against E. Coli
- Rexahn Pharmaceuticals Announces Publication of New Preclinical Research Data for Novel Anticancer Compound RX-8243
- Long Term Data Presented at ESC 2010 Shed Further Light on the Benefit of the CYPHER® Sirolimus Drug-Eluting Stent Compare
